دورية أكاديمية
Number of patients with interstitial cystitis/bladder pain syndrome seen before versus during the COVID-19 pandemic at an academic, urban, multisite urogynecology practice.
| العنوان: | Number of patients with interstitial cystitis/bladder pain syndrome seen before versus during the COVID-19 pandemic at an academic, urban, multisite urogynecology practice. |
|---|---|
| المؤلفون: | Markert T; Harvard Medical School, Boston, Massachusetts, USA., Courtepatte A; Division of Urogynecology, Brigham and Women's Hospital, Boston, Massachusetts, USA., Farah S; Harvard Medical School, Boston, Massachusetts, USA., Miranne JM; Harvard Medical School, Boston, Massachusetts, USA.; Division of Urogynecology, Brigham and Women's Hospital, Boston, Massachusetts, USA. |
| المصدر: | Lower urinary tract symptoms [Low Urin Tract Symptoms] 2023 Nov; Vol. 15 (6), pp. 247-255. Date of Electronic Publication: 2023 Sep 12. |
| نوع المنشور: | Journal Article |
| اللغة: | English |
| بيانات الدورية: | Publisher: Richmond, Vic. Country of Publication: Australia NLM ID: 101506777 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1757-5672 (Electronic) Linking ISSN: 17575664 NLM ISO Abbreviation: Low Urin Tract Symptoms Subsets: MEDLINE |
| أسماء مطبوعة: | Original Publication: Richmond, Vic. : Blackwell Publishing Asia, 2009- |
| مواضيع طبية MeSH: | Cystitis, Interstitial*/diagnosis , Cystitis, Interstitial*/epidemiology , Cystitis, Interstitial*/complications , COVID-19*/epidemiology , COVID-19*/complications, Humans ; Female ; Adult ; Pandemics ; Retrospective Studies |
| مستخلص: | Objectives: Little is known about the impact of the COVID-19 pandemic on interstitial cystitis/bladder pain syndrome (IC/BPS). We aim to compare the number of newly diagnosed IC/BPS cases and number of patients with flares prior to and during the pandemic. Methods: We conducted a retrospective cohort study of women ≥18 years who were diagnosed with or treated for IC/BPS between March 2019 and March 2021 at an academic, urban, multisite urogynecology practice. The primary outcome was the number of IC/BPS cases from March 1, 2019 to February 29, 2020 (pre-pandemic) compared with March 1, 2020 to February 28, 2021 (during pandemic). The secondary outcome was the number of patients with flares during those same two time periods. Demographic and clinical characteristics were compared using nonparametric tests and interrupted time series (ITS) was used to evaluate our outcomes of interest. p-Value <.05 was considered significant. Results: Fifty-four women (4.87% of new patients) were diagnosed with IC/BPS during the pandemic compared with 40 women pre-pandemic (4.05% of new patients). The median age was 35.0. Seventy-two percent were premenopausal, 75% sexually active, and 31% had anxiety, and there were no significant differences between groups. Although the number of patients newly diagnosed with IC/BPS was higher during the pandemic, the diagnosis rates between time periods were not statistically different. Thirty-five patients experienced flares during the pandemic compared with 49 patients the year prior (p = .43). This difference was also not statistically significant on ITS analysis. Conclusions: Although more patients were diagnosed with IC/BPS during versus before the pandemic, the difference in diagnosis rates was not different between these periods. (© 2023 John Wiley & Sons Australia, Ltd.) |
| References: | Hanno PM, Erickson D, Moldwin R, Faraday MM; American Urological Association. Diagnosis and treatment of interstitial cystitis/bladder pain syndrome: AUA guideline amendment. J Urol. 2015;193(5):1545-1553. doi:10.1016/j.juro.2015.01.086. McLennan MT. Interstitial cystitis: epidemiology, pathophysiology, and clinical presentation. Obstet Gynecol Clin North Am. 2014;41(3):385-395. doi:10.1016/j.ogc.2014.05.004. Malde S, Palmisani S, Al-Kaisy A, Sahai A. Guideline of guidelines: bladder pain syndrome. BJU Int. 2018;122(5):729-743. doi:10.1111/bju.14399. Patnaik SS, Laganà AS, Vitale SG, et al. Etiology, pathophysiology and biomarkers of interstitial cystitis/painful bladder syndrome. Arch Gynecol Obstet. 2017;295(6):1341-1359. doi:10.1007/s00404-017-4364-2. Patel R, Calhoun EA, Meenan RT, O'Keeffe Rosetti MC, Kimes T, Clemens JQ. Incidence and clinical characteristics of interstitial cystitis in the community. Int Urogynecol J Pelvic Floor Dysfunct. 2008;19(8):1093-1096. doi:10.1007/s00192-008-0573-3. Clemens JQ, Meenan RT, Rosetti MC, Gao SY, Calhoun EA. Prevalence and incidence of interstitial cystitis in a managed care population. J Urol. 2005;173(1):98-102; discussion 102. doi:10.1097/01.ju.0000146114.53828.82. Tyagi P, Moon CH, Janicki J, et al. Recent advances in imaging and understanding interstitial cystitis. F1000Res. 2018;7:F1000 Faculty Rev-1771. doi:10.12688/f1000research.16096.1. Lai HH, Vetter J, Song J, Andriole GL, Colditz GA, Sutcliffe S. Management of symptom flares and patient-reported flare triggers in interstitial cystitis/bladder pain syndrome (IC/BPS)-findings from one site of the MAPP research network. Urology. 2019;126:24-33. doi:10.1016/j.urology.2019.01.012. Lutgendorf SK, Kreder KJ, Rothrock NE, Ratliff TL, Zimmerman B. Stress and symptomatology in patients with interstitial cystitis: a laboratory stress model. J Urol. 2000;164(4):1265-1269. Rothrock NE, Lutgendorf SK, Kreder KJ, Ratliff T, Zimmerman B. Stress and symptoms in patients with interstitial cystitis: a life stress model. Urology. 2001;57(3):422-427. doi:10.1016/s0090-4295(00)00988-2. American Psychological Association. Stress and Decision-Making during the Pandemic. American Psychological Association; 2021 Accessed May 11, 2022. https://www.apa.org/news/press/releases/stress/2021/october-decision-making. Xiong J, Lipsitz O, Nasri F, et al. Impact of COVID-19 pandemic on mental health in the general population: a systematic review. J Affect Disord. 2020;277:55-64. doi:10.1016/j.jad.2020.08.001. COVID-19 Mental Disorders Collaborators. Global prevalence and burden of depressive and anxiety disorders in 204 countries and territories in 2020 due to the COVID-19 pandemic. Lancet. 2021;398(10312):1700-1712. doi:10.1016/S0140-6736(21)02143-7. Lamb LE, Timar R, Wills M, et al. Long COVID and COVID-19-associated cystitis (CAC). Int Urol Nephrol. 2022;54(1):17-21. doi:10.1007/s11255-021-03030-2. Commonwealth of Massachusetts, Office of Governor Charlie Baker and Lt. Governor Karyn Polito. Declaration of a State of Emergency to Respond to COVID-19, 3/10/2020. Massachusetts' COVID-19 Vaccination Phases. Mass.gov, Commonwealth of Massachusetts. Accessed May 10, 2022. www.mass.gov/info-details/massachusetts-covid-19-vaccination-phases. Clemens JQ, Erickson DR, Varela NP, Lai HH. Diagnosis and treatment of interstitial cystitis/bladder pain syndrome. J Urol. 2022;208:34-42. doi:10.1097/JU.0000000000002756. Schwab L. FDA announces Elmiron drug safety-related labeling changes. Drug Safety Developments. July 2, 2020. Accessed September 29, 2022. https://www.drug-injury.com/drug_injury/2020/07/fda-announces-elmiron-drug-safety-related-labeling-changes.html. Chen Y-C, Liang Y-C, Ho S-J, et al. Does COVID-19 vaccination cause storage lower urinary tract symptoms? J Clin Med. 2022;11(10):2736. doi:10.3390/jcm11102736. |
| معلومات مُعتمدة: | Brigham Research Institute |
| فهرسة مساهمة: | Keywords: COVID-19 pandemic; bladder pain syndrome; epidemiology; interstitial cystitis |
| تواريخ الأحداث: | Date Created: 20230913 Date Completed: 20231106 Latest Revision: 20231106 |
| رمز التحديث: | 20231215 |
| DOI: | 10.1111/luts.12502 |
| PMID: | 37700527 |
| قاعدة البيانات: | MEDLINE |
Full Text Finder كن أول من يترك تعليقا!